These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9061296)
21. Genomic alterations in malignant transformation of Barrett's esophagus. Riegman PH; Vissers KJ; Alers JC; Geelen E; Hop WC; Tilanus HW; van Dekken H Cancer Res; 2001 Apr; 61(7):3164-70. PubMed ID: 11306503 [TBL] [Abstract][Full Text] [Related]
22. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry. Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405 [TBL] [Abstract][Full Text] [Related]
23. Barrett's esophagus. The significance of p53 in clinical practice. Ireland AP; Clark GW; DeMeester TR Ann Surg; 1997 Jan; 225(1):17-30. PubMed ID: 8998117 [TBL] [Abstract][Full Text] [Related]
24. Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus. Doak SH; Jenkins GJ; Parry EM; D'Souza FR; Griffiths AP; Toffazal N; Shah V; Baxter JN; Parry JM Gut; 2003 May; 52(5):623-8. PubMed ID: 12692043 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic significance of nuclear p53 expression in the surveillance of Barrett's esophagus--a longitudinal study. Klump B; Hsieh CJ; Holzmann K; Borchard F; Gaco V; Greschniok A; Eckardt VF; Bettendorf U; Gregor M; Porschen R Z Gastroenterol; 1999 Oct; 37(10):1005-11. PubMed ID: 10549095 [TBL] [Abstract][Full Text] [Related]
26. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Guillem P; Billeret V; Buisine MP; Flejou JF; Lecomte-Houcke M; Degand P; Aubert JP; Triboulet JP; Porchet N Int J Cancer; 2000 Dec; 88(6):856-61. PubMed ID: 11093805 [TBL] [Abstract][Full Text] [Related]
27. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Galipeau PC; Cowan DS; Sanchez CA; Barrett MT; Emond MJ; Levine DS; Rabinovitch PS; Reid BJ Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7081-4. PubMed ID: 8692948 [TBL] [Abstract][Full Text] [Related]
28. Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. Schneider PM; Casson AG; Levin B; Garewal HS; Hoelscher AH; Becker K; Dittler HJ; Cleary KR; Troster M; Siewert JR; Roth JA J Thorac Cardiovasc Surg; 1996 Feb; 111(2):323-31; discussion 331-3. PubMed ID: 8583805 [TBL] [Abstract][Full Text] [Related]
30. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study. Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963 [TBL] [Abstract][Full Text] [Related]
34. Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma. Abraham JM; Meltzer SJ Gastroenterology; 2017 Jul; 153(1):27-34. PubMed ID: 28528706 [TBL] [Abstract][Full Text] [Related]
35. p53 immunoreactivity in Barrett's metaplasia, dysplasia, and adenocarcinoma--a case report. Kimura H; Konishi K; Kaji M; Maeda K; Yabushita K; Miwa A Hepatogastroenterology; 2001; 48(42):1662-4. PubMed ID: 11813596 [TBL] [Abstract][Full Text] [Related]
37. Applying big GWAS data to clarify the role of obesity in Barrett's esophagus and esophageal adenocarcinoma. Abrams JA; Chak A J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269700 [No Abstract] [Full Text] [Related]